Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by toinv261on Sep 06, 2014 12:23pm
142 Views
Post# 22912576

RE:Update Due

RE:Update DueHi SanFran.

Keep being a broken record!!! I agree with you on all points. We are all extremely frustrated by the lack of communications.

As I've stated in previous posts small cap companies in Alberta and BC are notorious for dirty deeds and ignoring shareholders once they have the shareholder's money. They tend to pay themselves very high salaries and benefits even though they don't perform. Don is a good example. He pays himself $40,000 plus per month even though he has never produced a nickel of profit. If the structure of the company was fair to shareholders Don would be paid $120,000 per year ($10,000/month) with options structured to give him very high incentives for each goal he achieves. That would set a sense of urgency in the company. At RVX they have to pay the doctors and scientists competitve wages or they will leave. In order to be at the top of the competitive game they must pay these people very well and I fully support this. They should be compensated at a much higher level than Don, afterall even a general practicioner can make $500,000 per year if they work extremely hard. This is not the case for Don. He should be compensated based on business performance...and he has not performed but he has kept the company alive.

The Constellation information gives us insight on a company that seems to be surpassing RVX in 6 years vs RVX at 14 years.

We all know there are good things happening at RVX and Zenith and we know this only because of the hard digging of you, Jkj, GV and other posters, and that is a pitty because the stories and progress should be out there.

I'm a broken record (do records still exist? :) lol )as well but I think we need to keep it up.

GLTA...still hopefull.
toinv


Bullboard Posts